Therapeutic benefits of ace inhibitors and other antihypertensive drugs in patients with type 2 diabetes

Diabetes Care

Volumn 24, Issue 1, 2001, Pages 177-178

  Parving, Hans Henrik ^a   Rossing, Peter ^a  

^a STENO DIABETES CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FOSINOPRIL; NISOLDIPINE;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DRUG EFFICACY; HEART INFARCTION; HUMAN; HYPERTENSION; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE;

EID: 0035138961     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.24.1.177-a     Document Type: Note

References (5)

1. Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes
2. Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in Patients with Hypertension and NIDDM
3. The effect of nisoldipine as compared with enalapril on cardiovascular events in patients with non-insulin-dependent diabetes and hypertension
4. Effect of angiotensin-converting-enzyme therapy on cardiovascular morbidity and mortality in hypertension: The Captopnl Prevention Project (CAPPP) randomized trial
5. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39